In silico based exploration of natural and synthetic antidiabetic compounds: A comprehensive review of computational approaches
ADMET and DMPK · 06.03.2026 · 14 · 3070
DOI: 10.5599/admet.3070 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ADMET and DMPK, online erschienen am 06.03.2026. Verfasst von Ahmad Fariz Maulana und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Sumedang, 45363, Indonesia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitas Padjadjaran.
Abstract (Originalsprache)
Background and purpose: Diabetes mellitus type 2 is a global health issue marked by hyperglycemia and metabolic dysfunction. Despite progress, discovering safe and effective antidiabetic agents remains crucial. This review highlights integrated In Silico, In Vitro, and in vivo methods for identifying novel antidiabetic compounds from natural and synthetic origins. Experimental approach: Computational tools including molecular docking, molecular dynamics, and ADMET prediction identified inhibitors targeting DPP-IV, α-glucosidase, and PPAR. Promising compounds underwent in vitro enzymatic and cellular assays, followed by in vivo efficacy tests in diabetic animal models assessing glucose levels, biochemical markers, and tissue histopathology. Key results: Integrated computational and experimental approaches effectively pinpointed compounds with strong target binding, enzyme inhibition, and positive cellular effects. In vivo data showed significant glucose reduction, enhanced insulin response, and pancreatic protection. ADMET analysis further supported their drug-likeness and safety profiles. Conclusion: Combining computational screening with biological validations forms a cost-effective pipeline for antidiabetic drug discovery. Multi-disciplinary integration increases lead identification success, guiding future refinement of in silico models and expanded in vivo studies to accelerate novel diabetes therapeutic development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Sumedang, 45363, Indonesia.
- Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, 45363, Indonesia.
- Department of Food Science, Faculty of Food Science and Technology, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.
ORCID-Profile: Ahmad Fariz Maulana, Sriwidodo Sriwidodo, Iman Permana Maksum, Yaya Rukayadi
Förderung
- Universitas Padjadjaran
Zitieren
APA
Maulana, A. F., Sriwidodo, S., Maksum, I. P., & Rukayadi, Y. (2026). In silico based exploration of natural and synthetic antidiabetic compounds: A comprehensive review of computational approaches. ADMET and DMPK, 14, 3070. https://doi.org/10.5599/admet.3070
Vancouver
Maulana AF, Sriwidodo S, Maksum IP, Rukayadi Y. In silico based exploration of natural and synthetic antidiabetic compounds: A comprehensive review of computational approaches. ADMET and DMPK. 2026;14:3070. doi:10.5599/admet.3070
BibTeX
@article{Maulana2026,
author = {Maulana, Ahmad Fariz and Sriwidodo, Sriwidodo and Maksum, Iman Permana and Rukayadi, Yaya},
title = {In silico based exploration of natural and synthetic antidiabetic compounds: A comprehensive review of computational approaches},
journal = {ADMET and DMPK},
year = {2026},
volume = {14},
pages = {3070},
doi = {10.5599/admet.3070}
}
EUVIMED